Brownstein Client Conversations: OvaCure
Kristin Parello-Plesner, Strategic Director for OvaCure, joins Brownstein Policy Advisor Araceli Gutierrez for a discussion on how OvaCure is challenging the current paradigms in cancer research. As OvaCure signed its first US-based ovarian cancer research project at the University of Pennsylvania, Brownstein has worked with OvaCure to connect with and establish a strong network of key US stakeholders. Kristin and Araceli discuss how U.S.-Danish relations can attract more innovation to the United States and highlight the importance of social philanthropy and its critical role in funding for ovarian cancer research.
Recent Insights
Read MoreAI Governance Takes Shape: Breaking Down Washington’s Latest AI Frameworks
Presentation | March 18, 2026State of Play
Client Alert | March 17, 2026FTC Seeks Comments on Rental Housing Fees and Negative Option Marketing
Client Alert | March 17, 2026Trump Issues Executive Orders on Mortgage Credit, Housing Construction
Water Blog Post | March 17, 2026SWIS 2026: The Big Signals Shaping Water’s Next Decade
Client Alert | March 17, 2026Revenue Strategies for Central Coast Landowners in Tough Agricultural Times
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.